Common management issues in pediatric patients with mild bleeding disorders.

Area of Science:

• Pediatric Hematology
• Hemostasis and Thrombosis

Background:

• Type 1 von Willebrand disease and mild platelet function defects are common in pediatric hematology.
• Clinical practice is challenged by limited data and a lack of randomized trials for managing these bleeding disorders.
• Desmopressin (DDAVP) and antifibrinolytics are primary treatments, but optimal use for efficacy and safety is often unclear.

Purpose of the Study:

• To provide practical management suggestions for common issues in children with mild bleeding disorders.
• To review the literature on managing epistaxis, heavy menstrual bleeding, dental extractions, and tonsillectomy.
• To highlight the importance of local measures and awareness of complications like DDAVP-induced hyponatremia.

Main Methods:

• Literature review of published data on mild bleeding disorders in children and adolescents.
• Discussion of treatment strategies including desmopressin (DDAVP) and antifibrinolytics.
• Focus on practical aspects of managing specific bleeding scenarios.

Main Results:

• Limited published data and lack of randomized trials complicate management decisions.
• Optimal dosing and timing of DDAVP and antifibrinolytics require careful consideration to balance efficacy and side effects.
• DDAVP-induced hyponatremia is an under-recognized surgical complication in children with bleeding disorders.
• Local hemostatic measures are crucial for managing epistaxis and surgical bleeding.

Conclusions:

• Effective management of mild bleeding disorders in pediatric patients requires awareness of current literature and practical strategies.
• Clinicians should consider both systemic treatments (DDAVP, antifibrinolytics) and local measures.
• Further research, including randomized clinical trials, is needed to optimize treatment protocols.